» Articles » PMID: 25015769

Bifunctional Roles of Survivin-ΔEx3 and Survivin-2B for Susceptibility to Apoptosis in Endometrial Carcinomas

Overview
Specialty Oncology
Date 2014 Jul 13
PMID 25015769
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Alternative splicing variants of survivin have different biological roles on cell kinetics. Here, we focused on the effects of different variants, including wild type (wt), survivin-ΔEx3, and survivin-2B, on apoptosis and cell proliferation in endometrial carcinomas (Em Cas).

Methods: Expression of survivin-wt, survivin-ΔEx3, and survivin-2B with reference to cell death and proliferation was investigated, using Em Ca cell lines and its clinical tissues.

Results: Ishikawa cells stably overexpressing either survivin-ΔEx3 (Surv-ΔEx3#34) or survivin-2B (Surv-2B#17) demonstrated considerably lower proliferative activity, along with up-regulation of p21. After TNF-α treatment, Surv-ΔEx3#34 cells showed an increase in apoptotic cells, while the effects were relatively minor in Surv-2B#17 cells. In contrast, doxorubicin treatment resulted in increased apoptotic cells in Surv-2B#17 but not Surv-ΔEx3#34 cells, along with decreased expression of bcl-2 relative to bax. Control Ishikawa cells also showed relatively higher endogenous mRNA expression of survivin-ΔEx3 and survivin-2B during treatment of TNF-α and doxorubicin, respectively. In addition, exogenous overexpression of each survivin variant resulted in inhibition of other endogenous isoforms, indicating that the relative proportion may contribute to regulation of the splicing machinery. In clinical samples, level of survivin-ΔEx3 relative to either survivin-wt or survivin-2B was significantly higher in Em Cas than non-neoplastic lesions. Moreover, survivin-ΔEx3 and survivin-wt were positively correlated with apoptosis and cell proliferation, respectively, in Em Cas.

Conclusions: These findings provided evidence that the balance among expression level of survivin variants may contribute to modulation of cell kinetics in Em Ca cells.

Citing Articles

The potential impact of RNA splicing abnormalities on immune regulation in endometrial cancer.

Cao M, Yan J, Ding Y, Zhang Y, Sun Y, Jiang G Cell Death Dis. 2025; 16(1):148.

PMID: 40032844 PMC: 11876696. DOI: 10.1038/s41419-025-07458-7.


Decreased BIRC5-206 promotes epithelial-mesenchymal transition in nasopharyngeal carcinoma through sponging miR-145-5p.

Xu W, Hu J, Ma Z, Feng W, Gong W, Fu S Open Med (Wars). 2024; 19(1):20241007.

PMID: 39308922 PMC: 11416051. DOI: 10.1515/med-2024-1007.


Effects of Topoisomerase II alpha Inhibition on Oral Cancer Cell Metabolism and Cancer Stem Cell Function.

Kanagasabai T, Hawaz M, Ellis K, Fah O, Mikhaeil H, Nguyen P Dent Res Oral Health. 2024; 7(2):58-65.

PMID: 38957610 PMC: 11218736. DOI: 10.26502/droh.0076.


Potential anticancer properties of calotropis procera: An investigation on breast and colon cancer cells.

Bou Malhab L, Bajbouj K, Shehab N, Elayoty S, Sinoj J, Adra S Heliyon. 2023; 9(6):e16706.

PMID: 37332907 PMC: 10272338. DOI: 10.1016/j.heliyon.2023.e16706.


Survivin as a novel target protein for reducing the proliferation of cancer cells.

Li D, Hu C, Li H Biomed Rep. 2018; 8(5):399-406.

PMID: 29725522 PMC: 5920485. DOI: 10.3892/br.2018.1077.


References
1.
Noton E, Colnaghi R, Tate S, Starck C, Carvalho A, Ko Ferrigno P . Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis. J Biol Chem. 2005; 281(2):1286-95. DOI: 10.1074/jbc.M508773200. View

2.
Caldas H, Jiang Y, Holloway M, Fangusaro J, Mahotka C, Conway E . Survivin splice variants regulate the balance between proliferation and cell death. Oncogene. 2005; 24(12):1994-2007. DOI: 10.1038/sj.onc.1208350. View

3.
Saegusa M, Hashimura M, Kuwata T, Okayasu I . Requirement of the Akt/beta-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of slug. Am J Pathol. 2009; 174(6):2107-15. PMC: 2684176. DOI: 10.2353/ajpath.2009.081018. View

4.
Saegusa M, Hashimura M, Suzuki E, Yoshida T, Kuwata T . Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway. Am J Pathol. 2012; 181(2):684-92. DOI: 10.1016/j.ajpath.2012.05.008. View

5.
Kappler M, Kohler T, Kampf C, Diestelkotter P, Wurl P, Schmitz M . Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer. 2001; 95(6):360-3. DOI: 10.1002/1097-0215(20011120)95:6<360::aid-ijc1063>3.0.co;2-1. View